{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:38:08Z","timestamp":1790534288325,"version":"4.1.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cancertreatmentreviews.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.ctrv.2016.03.001","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T09:46:54Z","timestamp":1457344014000},"page":"58-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Optimize and refine therapeutic index in radiation therapy: Overview of a century"],"prefix":"10.1016","volume":"45","author":[{"given":"Cyrus","family":"Chargari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Magne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Rancoule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonin","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyn A.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2016.03.001_b0005","first-page":"254","article-title":"Erfahrungen \u00fcber die Vertr\u00e4glichkeitsgrenze f\u00fcr R\u00f6ntgenstrahlen und deren Nutzanwendung zur Verh\u00fctung von Sch\u00e4den","volume":"57","author":"Holthusen","year":"1936","journal-title":"Strahlentherapie"},{"key":"10.1016\/j.ctrv.2016.03.001_b0010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM197507102930206","article-title":"Normal tissue responses to radiation therapy","volume":"293","author":"Bloomer","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2016.03.001_b0015","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nrc1451","article-title":"Radiation oncology: a century of achievements","volume":"4","author":"Bernier","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ctrv.2016.03.001_b0020","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nrc2587","article-title":"Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype","volume":"9","author":"Barnett","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ctrv.2016.03.001_b0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/annonc\/mds217","article-title":"Controversies and challenges regarding the impact of radiation therapy on survival","volume":"24","author":"Chargari","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.drup.2013.01.001","article-title":"Understanding the functions of tumor stroma in resistance to ionizing radiation: emerging targets for pharmacological modulation","volume":"16","author":"Chargari","year":"2013","journal-title":"Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother"},{"key":"10.1016\/j.ctrv.2016.03.001_b0035","series-title":"The four R\u2019s of radiotherapy","author":"Withers","year":"1975"},{"key":"10.1016\/j.ctrv.2016.03.001_b0040","first-page":"85","article-title":"The theory of dual radiation action","volume":"8","author":"Kellerer","year":"1972","journal-title":"Top Radiat Res"},{"key":"10.1016\/j.ctrv.2016.03.001_b0045","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/0360-3016(85)90223-8","article-title":"Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves","volume":"11","author":"Fertil","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.03.001_b0050","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0360-3016(81)90377-1","article-title":"Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy","volume":"7","author":"Fertil","year":"1981","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.03.001_b0055","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","article-title":"The linear-quadratic formula and progress in fractionated radiotherapy","volume":"62","author":"Fowler","year":"1989","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(97)06305-8","article-title":"Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee","volume":"350","author":"Saunders","year":"1997","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ctrv.2016.03.001_b0065","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":"Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ctrv.2016.03.001_b0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0075","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ijrobp.2008.10.091","article-title":"Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials","volume":"74","author":"Viani","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.03.001_b0080","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ijrobp.2013.07.041","article-title":"Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial","volume":"87","author":"Michalski","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.03.001_b0085","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1200\/JCO.2013.51.1972","article-title":"Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer","volume":"31","author":"Pollack","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0090","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ijrobp.2013.06.2059","article-title":"Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study","volume":"87","author":"Gandhi","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.03.001_b0095","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1200\/JCO.2013.49.7842","article-title":"Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis","volume":"31","author":"Mukesh","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0100","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG)","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2016.03.001_b0105","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2016.03.001_b0110","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1200\/JCO.2005.13.755","article-title":"Cardiac morbidity of adjuvant radiotherapy for breast cancer","volume":"23","author":"Patt","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0115","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2016.03.001_b0120","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1148\/82.6.1032","article-title":"Dose\u2013time\u2013volume relationship in squamous-cell carcinoma of the larynx","volume":"82","author":"Fletcher","year":"1964","journal-title":"Radiology"},{"key":"10.1016\/j.ctrv.2016.03.001_b0125","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ijrobp.2009.09.040","article-title":"Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues","volume":"76","author":"Bentzen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.03.001_b0130","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.03.001_b0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.radonc.2012.05.008","article-title":"Biological mechanisms of normal tissue damage: importance for the design of NTCP models","volume":"105","author":"Trott","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0140","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nrclinonc.2011.44","article-title":"Oligometastases revisited","volume":"8","author":"Weichselbaum","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0145","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","article-title":"Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial","volume":"295","author":"Aoyama","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ctrv.2016.03.001_b0150","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","article-title":"Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial","volume":"10","author":"Chang","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0155","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1093\/annonc\/mdu477","article-title":"Focal or combined modality for the management of brain metastasis: did high tech radiotherapy superseded drug-radiotherapy combination?","volume":"25","author":"Deutsch","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0160","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.lungcan.2011.07.018","article-title":"PET scans in radiotherapy planning of lung cancer","volume":"75","author":"De Ruysscher","year":"2012","journal-title":"Lung Cancer Amst Neth"},{"key":"10.1016\/j.ctrv.2016.03.001_b0165","first-page":"253","article-title":"Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy","volume":"46","author":"Eschmann","year":"2005","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"10.1016\/j.ctrv.2016.03.001_b0170","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S1474-4422(10)70181-2","article-title":"Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas","volume":"9","author":"Dhermain","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2013.05.033","article-title":"Trends in the utilization of brachytherapy in cervical cancer in the United States","volume":"87","author":"Han","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.03.001_b0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijrobp.2008.06.1912","article-title":"Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients","volume":"74","author":"Chargari","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.03.001_b0185","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0190","first-page":"CD002140","article-title":"Concurrent chemoradiotherapy in non-small cell lung cancer","author":"O\u2019Rourke","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ctrv.2016.03.001_b0195","first-page":"CD008285","article-title":"Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis","author":"Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC)","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ctrv.2016.03.001_b0200","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2016.03.001_b0205","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199707173370304","article-title":"Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus","volume":"337","author":"Bosset","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2016.03.001_b0210","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"Van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2016.03.001_b0215","article-title":"Gemzar\u00ae (gemcitabine) with thoracic radiotherapy \u2013 a phase II pilot study in chemonaive patients with advanced non-small cell lung cancer","author":"Scalliet","year":"1998","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0220","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0225","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ncponc0048","article-title":"Mechanisms of disease: radiosensitization by epidermal growth factor receptor inhibitors","volume":"1","author":"Sartor","year":"2004","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0230","doi-asserted-by":"crossref","first-page":"31182","DOI":"10.1074\/jbc.M506591200","article-title":"Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase","volume":"280","author":"Dittmann","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ctrv.2016.03.001_b0235","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1470-2045(13)70136-0","article-title":"Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2\/3 randomised trial","volume":"14","author":"Crosby","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0240","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1308345","article-title":"Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma","volume":"370","author":"Chinot","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2016.03.001_b0245","doi-asserted-by":"crossref","first-page":"e26073","DOI":"10.1371\/journal.pone.0026073","article-title":"Bioluminescent orthotopic mouse models of human localized non-small cell lung cancer: feasibility and identification of circulating tumour cells","volume":"6","author":"Mordant","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ctrv.2016.03.001_b0250","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.critrevonc.2007.10.003","article-title":"The use of xenograft models for the selection of cancer treatments with the EGFR as an example","volume":"65","author":"Troiani","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0255","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1053\/j.seminoncol.2005.03.009","article-title":"Non-small cell lung cancer therapy-related pulmonary toxicity: an update on radiation pneumonitis and fibrosis","volume":"32","author":"Kong","year":"2005","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0260","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1200\/JCO.2000.18.19.3339","article-title":"Phase III randomized trial of amifostine as a radioprotector in head and neck cancer","volume":"18","author":"Brizel","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0265","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1200\/JCO.2003.06.064","article-title":"Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis","volume":"21","author":"Delanian","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0270","first-page":"106","article-title":"Seeds and soil: unraveling the role of local tumor stroma in distant metastasis","author":"Duda","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctrv.2016.03.001_b0275","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1158\/0008-5472.CAN-10-1040","article-title":"AACR centennial series: the biology of cancer metastasis: historical perspective","volume":"70","author":"Talmadge","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2016.03.001_b0280","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrm1261","article-title":"Met, metastasis, motility and more","volume":"4","author":"Birchmeier","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0285","doi-asserted-by":"crossref","first-page":"e15313","DOI":"10.1371\/journal.pone.0015313","article-title":"Breast cancer cells induce cancer-associated fibroblasts to secrete hepatocyte growth factor to enhance breast tumorigenesis","volume":"6","author":"Tyan","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ctrv.2016.03.001_b0290","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1111\/j.1349-7006.2008.00978.x","article-title":"Irradiated fibroblast-induced bystander effects on invasive growth of squamous cell carcinoma under cancer-stromal cell interaction","volume":"99","author":"Kamochi","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ctrv.2016.03.001_b0295","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","article-title":"Matrix crosslinking forces tumor progression by enhancing integrin signaling","volume":"139","author":"Levental","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ctrv.2016.03.001_b0300","doi-asserted-by":"crossref","first-page":"10861","DOI":"10.1158\/0008-5472.CAN-06-2565","article-title":"Inhibition of transforming growth factor-beta1 signaling attenuates ataxia telangiectasia mutated activity in response to genotoxic stress","volume":"66","author":"Kirshner","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2016.03.001_b0305","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1158\/0008-5472.CAN-11-1212","article-title":"Blockade of TGF-\u03b2 signaling by the TGF\u03b2R-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma","volume":"71","author":"Zhang","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2016.03.001_b0310","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","article-title":"TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Immunol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0315","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI30082","article-title":"The pancreatic stellate cell: a star on the rise in pancreatic diseases","volume":"117","author":"Omary","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ctrv.2016.03.001_b0320","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.cell.2010.02.015","article-title":"Decoding cell death signals in inflammation and immunity","volume":"140","author":"Zitvogel","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ctrv.2016.03.001_b0325","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1158\/2326-6066.CIR-14-0002","article-title":"The carcinoma-associated fibroblast expressing fibroblast activation protein and escape from immune surveillance","volume":"2","author":"Fearon","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ctrv.2016.03.001_b0330","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrc2603","article-title":"Radiation-induced bystander signalling in cancer therapy","volume":"9","author":"Prise","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ctrv.2016.03.001_b0335","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1667\/RR2548.1","article-title":"Radiation-induced bystander effects: what are they, and how relevant are they to human radiation exposures?","volume":"176","author":"Blyth","year":"2011","journal-title":"Radiat Res"},{"key":"10.1016\/j.ctrv.2016.03.001_b0340","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1470-2045(09)70082-8","article-title":"Systemic effects of local radiotherapy","volume":"10","author":"Formenti","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0345","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/1874467211104020096","article-title":"Radiation induced non-targeted response: mechanism and potential clinical implications","volume":"4","author":"Hei","year":"2011","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0350","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0360-3016(90)90136-8","article-title":"The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines","volume":"19","author":"Hallahan","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.03.001_b0355","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1200\/JCO.2004.01.227","article-title":"TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors","volume":"22","author":"Senzer","year":"2004","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0360","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1200\/JCO.2012.44.7516","article-title":"Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results","volume":"31","author":"Herman","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0365","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijrobp.2009.04.038","article-title":"Combination of the pro-apoptotic TRAIL-receptor antibody mapatumumab with ionizing radiation strongly increases long-term tumor control under ambient and hypoxic conditions","volume":"75","author":"Marini","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.03.001_b0370","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00262-010-0877-2","article-title":"The effect of radiotherapy on NKT cells in patients with advanced head and neck cancer","volume":"59","author":"Kobayashi","year":"2010","journal-title":"Cancer Immunol Immunother"},{"issue":"31","key":"10.1016\/j.ctrv.2016.03.001_b0375","first-page":"885","article-title":"Intratumoral dendritic cells and chemoradiation for the treatment of murine squamous cell carcinoma","volume":"2008","author":"Moyer","year":"1997","journal-title":"J Immunother Hagerstown Md"},{"key":"10.1016\/j.ctrv.2016.03.001_b0380","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-09-0265","article-title":"Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody","volume":"15","author":"Dewan","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2016.03.001_b0385","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1158\/0008-5472.CAN-04-0073","article-title":"External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing","volume":"64","author":"Chakraborty","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2016.03.001_b0390","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1158\/2326-6066.CIR-14-0138","article-title":"PD-1 restrains radiotherapy-induced abscopal effect","volume":"3","author":"Park","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ctrv.2016.03.001_b0395","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","article-title":"Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries","volume":"12","author":"Berrington de Gonzalez","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2006.01.027","article-title":"Intensity-modulated radiation therapy, protons, and the risk of second cancers","volume":"65","author":"Hall","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.03.001_b0405","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.ijrobp.2009.07.011","article-title":"Radiation-induced cancers from modern radiotherapy techniques: intensity-modulated radiotherapy versus proton therapy","volume":"77","author":"Yoon","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.03.001_b0410","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/annonc\/mdt156","article-title":"Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma","volume":"24","author":"Maraldo","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0415","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijrobp.2013.04.030","article-title":"Incidence of second malignancies among patients treated with proton versus photon radiation","volume":"87","author":"Chung","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.03.001_b0420","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0425","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.ijrobp.2012.11.006","article-title":"Protons in head-and-neck cancer: bridging the gap of evidence","volume":"85","author":"Ramaekers","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.03.001_b0430","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.radonc.2012.10.017","article-title":"Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity","volume":"105","author":"Barnett","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0435","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1158\/1078-0432.CCR-04-2634","article-title":"CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients","volume":"11","author":"Ozsahin","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2016.03.001_b0440","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ijrobp.2014.01.002","article-title":"Relationship between radiation-induced apoptosis of T lymphocytes and chronic toxicity in patients with prostate cancer treated by radiation therapy: a prospective study","volume":"88","author":"Foro","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.03.001_b0445","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ijrobp.2009.06.014","article-title":"A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation","volume":"75","author":"Eschrich","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.03.001_b0450","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1200\/JCO.2008.17.7188","article-title":"DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer","volume":"27","author":"Iacobuzio-Donahue","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0455","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/annonc\/mdr130","article-title":"The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN)","volume":"22","author":"Hristozova","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0460","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.radonc.2015.02.015","article-title":"CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma","volume":"114","author":"Coroller","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0465","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1038\/ncomms5006","article-title":"Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach","volume":"5","author":"Aerts","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.ctrv.2016.03.001_b0470","first-page":"106","article-title":"Randomized trial of erlotinib plus whole-brain radiotherapy for NSCLC patients with multiple brain metastases","author":"Lee","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctrv.2016.03.001_b0475","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/bjc.2012.236","article-title":"Normal tissues toxicities triggered by combined anti-angiogenic and radiation therapies: hurdles might be ahead","volume":"107","author":"Mangoni","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2016.03.001_b0480","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijrobp.2013.05.012","article-title":"Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT)","volume":"87","author":"Barney","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.03.001_b0485","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1200\/JCO.2011.38.4552","article-title":"Pulmonary toxicity after bevacizumab and concurrent thoracic radiotherapy observed in a phase I study for inoperable stage III non-small-cell lung cancer","volume":"30","author":"Lind","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0490","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.clon.2014.03.011","article-title":"An isotoxic planning comparison study for stage II\u2013III non-small cell lung cancer: is intensity-modulated radiotherapy the answer?","volume":"26","author":"Warren","year":"2014","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0495","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ijrobp.2014.12.012","article-title":"Individualized positron emission tomography-based isotoxic accelerated radiation therapy is cost-effective compared with conventional radiation therapy: a model-based evaluation","volume":"91","author":"Bongers","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.ctrv.2016.03.001_b0500","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/JTO.0000000000000151","article-title":"A phase I study of concurrent individualized, isotoxic accelerated radiotherapy and cisplatin\u2013vinorelbine\u2013cetuximab in patients with stage III non-small-cell lung cancer","author":"Dingemans","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2015.07.1465","article-title":"Evaluation of health economics in radiation oncology: a systematic review","author":"Nguyen","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctrv.2016.03.001_b0510","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s40258-014-0106-9","article-title":"Systematic review of the cost effectiveness of radiation therapy for prostate cancer from 2003 to 2013","volume":"12","author":"Amin","year":"2014","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.ctrv.2016.03.001_b0515","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.clon.2012.05.004","article-title":"Cost-effectiveness of intensity-modulated radiotherapy in prostate cancer","volume":"24","author":"Yong","year":"2012","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0520","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.brachy.2012.04.002","article-title":"Brachytherapy provides comparable outcomes and improved cost-effectiveness in the treatment of low\/intermediate prostate cancer","volume":"11","author":"Shah","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctrv.2016.03.001_b0525","doi-asserted-by":"crossref","DOI":"10.1111\/ecc.12430","article-title":"Cost-effectiveness analysis of intensity-modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer","author":"Zempl\u00e9nyi","year":"2016","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.ctrv.2016.03.001_b0530","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.radonc.2015.01.005","article-title":"Spacers in radiotherapy treatment of prostate cancer: is reduction of toxicity cost-effective?","volume":"114","author":"Vanneste","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0535","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/COC.0b013e318282a850","article-title":"Costs of care in a matched pair comparison of intensity-modulated radiation therapy (IMRT) versus conventional radiation therapy (CRT) for the treatment of head and neck cancer","volume":"37","author":"Sheets","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0540","first-page":"106:dju008","article-title":"Examining the cost-effectiveness of radiation therapy among older women with favorable-risk breast cancer","author":"Sen","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctrv.2016.03.001_b0545","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ygyno.2014.12.039","article-title":"Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers","volume":"136","author":"Chen","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ctrv.2016.03.001_b0550","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ctrv.2010.02.018","article-title":"The cost-effectiveness of particle therapy in non-small cell lung cancer: exploring decision uncertainty and areas for future research","volume":"36","author":"Grutters","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ctrv.2016.03.001_b0555","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1349-7006.2010.01604.x","article-title":"Cost-effectiveness of carbon ion radiation therapy for locally recurrent rectal cancer","volume":"101","author":"Mobaraki","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ctrv.2016.03.001_b0560","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.29882","article-title":"A systematic review of the cost and cost-effectiveness studies of proton radiotherapy","author":"Verma","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2016.03.001_b0565","doi-asserted-by":"crossref","first-page":"173sr2","DOI":"10.1126\/scitranslmed.3005148","article-title":"New paradigms and future challenges in radiation oncology: an update of biological targets and technology","volume":"5","author":"Liauw","year":"2013","journal-title":"Sci Transl Med"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737216000335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737216000335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T08:41:34Z","timestamp":1567672894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737216000335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":113,"alternative-id":["S0305737216000335"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2016.03.001","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimize and refine therapeutic index in radiation therapy: Overview of a century","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2016.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}